CoraLite® Plus 488-conjugated BCL9 Recombinant antibody

BCL9 Uni-rAbTM Recombinant Antibody for IF/ICC
Cat No. CL488-83760-3
Clone No.240682A9

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

IF/ICC

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  CoraLite® Plus 488
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive IF/ICC detected inHeLa cells

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

CL488-83760-3 targets BCL9 in IF/ICC applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen BCL9 fusion protein Ag19158 Predict reactive species
Full Name B-cell CLL/lymphoma 9
Calculated Molecular Weight 1426 aa, 149 kDa
GenBank Accession NumberBC116451
Gene Symbol BCL9
Gene ID (NCBI) 607
Conjugate CoraLite® Plus 488 Fluorescent Dye
Excitation/Emission Maxima Wavelengths493 nm / 522 nm
Form Liquid
Purification MethodProtein A purification
UNIPROT IDO00512
Storage Buffer PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Protocols

Product Specific Protocols
IF protocol for CL Plus 488 BCL9 antibody CL488-83760-3Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...